Medicines Supply Tender - Department of Military Affairs

Lignocaine HCl 2 percent without Adrenalin 30 ml Inj suitable for ophthalmic use also,Lignocaine HC

Goods
Qty:45.8K

Tender Timeline

Tender Issue
June 5, 2025 at 1:02 PM

Tender Title: Medicines Supply Tender

Reference Number: 149c658cd
Issuing Authority/Department: Department of Military Affairs, Ministry of Defence

The Medicines Supply Tender seeks to procure a comprehensive list of medicinal products, specifically designed for healthcare applications within military settings. The tender encompasses a total supply of 45,783 units of various pharmaceutical items, including but not limited to Lignocaine HCl 2 percent (without Adrenaline 30 ml), Atropine Sulphate, Pregabalin, and Paracetamol with Cysteine HCl among others. These medicines are crucial for maintaining the healthcare standards mandated for military personnel.

Scope of Work and Objectives

The primary objective is to ensure a reliable and timely supply of specific medicinal products that cater to the needs of military healthcare services. Suppliers must demonstrate their ability to meet standard requirements for quality, safety, and efficacy while providing a consistent supply chain.

Eligibility Criteria

To qualify for participation in this tender, bidders must meet stringent eligibility benchmarks. These include being a registered entity with relevant healthcare or pharmaceutical licenses, compliance with regulatory standards, and the ability to deliver the required medicines efficiently.

Technical Requirements

All products supplied must comply with national health standards, and participants should provide requisite certifications validating the quality and safety of the medicines. Suppliers must be capable of providing important documentation such as safety data sheets and quality assurance certificates.

Financial Requirements

While specific financial criteria are often dictated by the procurement policies, participants must demonstrate fiscal responsibility, which includes the ability to sustain the financial implications of a bulk order. Bidders may also be required to furnish documentation supporting their creditworthiness and previous experience in handling similar contracts.

Document Submission Details

Bidders must submit the necessary proposal documents electronically via the prescribed online platform. Detailed instructions regarding the submission process, including required documentation and potential formats for electronic submissions, will be provided by the issuing authority.

Special Provisions

This tender includes provisions for Micro, Small, and Medium Enterprises (MSEs). Eligible MSEs may benefit from reduced financial guarantees and lower bidding thresholds to encourage their participation. Startups are also encouraged to engage in this tender, provided they meet the necessary technical and eligibility criteria.

Evaluation Process

All received bids will undergo a systematic evaluation process where technical capabilities will be assessed first, followed by financial evaluation. Criteria will include compliance with quality standards, delivery capabilities, and pricing judgments. Successful bidders will be those who provide the best value while adhering to all stipulations set forth in the tender documentation.

Delivery Locations

Products are expected to be delivered at various healthcare facilities, designated by the Ministry of Defence. Participants must demonstrate experience in handling logistics effectively, ensuring timely delivery without compromising product quality.

Contact Information

While specific contact details are not publicly available, participants are encouraged to reach out through the official channels provided in the tendering platform for any queries or clarifications related to this tender.

This tender represents an opportunity for qualified suppliers to align their services with the healthcare needs of military personnel, focusing on quality, reliability, and efficiency across the supply chain.


Tender BOQ Items

52 Items
1.

Lignocaine HCl 2 percent without Adrenalin 30 ml Inj suitable for ophthalmic use also

Qty:30
Unit:amp vial
20
2.

Lignocaine HCl 2 percent with Adrenaline 1.80000 30 ml Inj

Qty:70
Unit:amp vial
20
3.

Atropine Sulphate 0.6 mg, 1 ml Inj

Qty:300
Unit:amp vial
20
4.

Paracetamol with Cysteine HCl monohydrate infusion 1000 mg or 100 ml

Qty:600
Unit:bott
20
5.

Pregabalin 75 mg plus Methylcobalamine 1500 mcg Tab

Qty:3000
Unit:no
20
6.

Pheniramine Maleate Inj 22.75 mg ml amp of 2 ml

Qty:300
Unit:amp vial
20
7.

Noradrenaline Bitartrate 2 mg ml, 2 ml Inj

Qty:20
Unit:amp vial
20
8.

Lorazepam 2 mg or ml, 2 ml Inj

Qty:240
Unit:amp vial
20
9.

Inj Fosphenytoin 75 mg or ml, 2ml ampoule

Qty:30
Unit:amp vial
20
10.

Albendazole Syp, each 5 ml containing 200 mg, bott of 10 ml

Qty:300
Unit:bott
20
11.

Tab Artesunate 25 mg plus Sulphadoxine 250 mg and Pyrimethamine 12.5 mg

Qty:300
Unit:kit
20
12.

Chloroquine Phosphate 250 mg Tab

Qty:7500
Unit:no
20
13.

Primaquine 7.5mg base Tab

Qty:3000
Unit:no
20
14.

Tranexamic Acid 500 mg or 5ml Inj

Qty:45
Unit:amp vial
20
15.

Isosorbide Dinitrate 10 mg Tab

Qty:900
Unit:no
20
16.

Adenosine 3 mg or ml, 2 ml Inj

Qty:18
Unit:amp vial
20
17.

Propranolol TR 40 mg, Tab

Qty:1500
Unit:no
20
18.

Ramipiril 2.5 mg Tab

Qty:2400
Unit:no
20
19.

Labetalol HCl 5mg or ml, 4ml Inj

Qty:30
Unit:amp vial
20
20.

Chlorhexidine mouth wash with 0.12 percent sugar, alcohol free, bottle of 450 to 500 ml in amber coloured bottle

Qty:150
Unit:bott
20
21.

Mupirocin 2 percent Oint, tube of 5 gm

Qty:1500
Unit:tube
20
22.

Sodium Hypochlorite 5 percentage

Qty:30
Unit:ltr
20
23.

Hydrogen peroxide solution with stabilizer IP 20 volume 500 ml bott

Qty:30
Unit:bott
20
24.

Povidone Iodine solution 5 percent bottle of 100 ml

Qty:450
Unit:bott
20
25.

Antispasmodic Tab containing Mefenamic Acid 250 mg and Dicyclomine HCl 10 mg

Qty:4500
Unit:no
20
26.

Antacid Gel each 5ml containing dried Aluminium Hydroxide gel IP 250mg, Magnesium hydroxide NF 250mg and Methyl Polysiloxane 50mg Bottle of 170 ml

Qty:1800
Unit:bott
20
27.

Anti haemorrhoidal ointment containing Hydrocortisone acetate 5.58mg, Framycetin 10mg, Heparin 100IU, Esculoside 10mg, Ethylaminobenzoate 10mg, Butylaminobenzoate 10mg per gm tube of 10 gm

Anti haemorrhoidal ointment containing Hydrocortisone acetate 5.58mg, Framycetin 10mg, Heparin 100IU, Esculoside 10mg, Ethylaminobenzoate 10mg, Butylaminobenzoate 10mg per gm tube of 10 gm with applicator

Qty:360
Unit:tube
20
28.

Dicyclomine HCl 20mg Inj

Qty:600
Unit:amp vial
20
29.

Hyoscine Bromide Inj 20 mg or ml ,1ml Inj

Qty:300
Unit:amp vial
20
30.

Oral Rehydration powder, sachet of 20.5 g, each containing Sodium Chloride IP 2.6 g, Anhydrous Dextrose IP 13.5 g, Potassium Chloride IP 1.5 g and Sodium Citrate IP 2.9 gm to make the mixture

Qty:4500
Unit:sachet
20
31.

Loperamide 2mg Tab

Qty:390
Unit:no
20
32.

Tab Thyroxine 50 mcg

Qty:1800
Unit:no
20
33.

Xylometazoline HCl 0.05 percent wv nasal solution for paed use, bott of 10ml

Qty:150
Unit:bott
20
34.

Cetirizine Syp 5mg or 5ml bott of 60 ml

Qty:360
Unit:bott
20
35.

Cyproheptadine HCl 2 mg or 5 ml bott of 100 ml

Qty:90
Unit:bott
20
36.

Ondansetron Syp 2 mg or 5ml in bott of 30 ml

Qty:150
Unit:bott
20
37.

Iron drops Paediatric. Each ml contains Ferrous Fumarate containing 10 12.5 mg elemental Iron, Folic Acid 0.1 0.5 mg and Vit B12 3 10 mcg, bottle of 15 ml

Qty:300
Unit:bott
20
38.

Ipratropium Bromide Respirator soln 500 mcg 2 ml respule

Qty:180
Unit:no
20
39.

Levo Salbutamol aerosol pack of 200 metered doses each metered dose supplies 50 mcg of Levo Salbutamol

Qty:90
Unit:inhaler
20
40.

Levo Salbutamol Sulphate, 2.5 ml, containing 1.25 mg, Respule

Qty:600
Unit:amp vial
20
41.

Dextrose Inj 25 percent, 25 ml Inj

Qty:150
Unit:amp vial
20
42.

Multi Vit Inj IV 2 10 ml with minimum constituents having Thiamine B1 30mg or ml, Pyridoxine B6 30mg or ml and B12 Cyanocobalamin 300 mcg or ml

Qty:120
Unit:amp vial
20
43.

Tab Etoricoxib 90 mg

Qty:300
Unit:no
20
44.

Amoxycillin oral susp containing Amoxycillin base 125 mg per 5 ml after reconstitution bottle of 30 ml

Qty:60
Unit:bott
20
45.

Artemether 80 mg, Lumefantrine 480 mg Tablet

Qty:600
Unit:no
20
46.

Tetanus Toxoid, purified, absorbed rubber capped, Vial of 5 ml 10 Doses

Qty:300
Unit:amp vial
20
47.

Tab Aceclofenac Sodium 100mg plus Paracetamol 500mg

Qty:3600
Unit:no
20
48.

Syp Chlopheniramine Maleate Maleate 1mg plus Phenylephrine 2.5 mg bott of 100ml

Qty:300
Unit:bott
20
49.

Oint Povidine Iodine tube of 30gm

Qty:600
Unit:tube
20
50.

Mouth ulcer gel tube of 10 gm Choline Salicylate

Qty:300
Unit:tube
20
51.

Diclofenac Spray bott of 60ml

Qty:390
Unit:no
20
52.

Betadine Gargle bott of 100ml

Qty:150
Unit:bott
20

General Information

Item Category
Lignocaine HCl 2 percent without Adrenalin 30 ml Inj suitable for ophthalmic use also , Lignocaine HCl 2 percent with Adrenaline 1.80000 30 ml Inj , Atropine Sulphate 0.6 mg, 1 ml Inj , Paracetamol with Cysteine HCl monohydrate infusion 1000 mg or 100 ml , Pregabalin 75 mg plus Methylcobalamine 1500 mcg Tab , Pheniramine Maleate Inj 22.75 mg ml amp of 2 ml , Noradrenaline Bitartrate 2 mg ml, 2 ml Inj , Lorazepam 2 mg or ml, 2 ml Inj , Inj Fosphenytoin 75 mg or ml, 2ml ampoule , Albendazole Syp, each 5 ml containing 200 mg, bott of 10 ml , Tab Artesunate 25 mg plus Sulphadoxine 250 mg and Pyrimethamine 12.5 mg , Chloroquine Phosphate 250 mg Tab , Primaquine 7.5mg base Tab , Tranexamic Acid 500 mg or 5ml Inj , Isosorbide Dinitrate 10 mg Tab , Adenosine 3 mg or ml, 2 ml Inj , Propranolol TR 40 mg, Tab , Ramipiril 2.5 mg Tab , Labetalol HCl 5mg or ml, 4ml Inj , Chlorhexidine mouth wash with 0.12 percent sugar, alcohol free, bottle of 450 to 500 ml in amber coloured bottle , Mupirocin 2 percent Oint, tube of 5 gm , Sodium Hypochlorite 5 percentage , Hydrogen peroxide solution with stabilizer IP 20 volume 500 ml bott , Povidone Iodine solution 5 percent bottle of 100 ml , Antispasmodic Tab containing Mefenamic Acid 250 mg and Dicyclomine HCl 10 mg , Antacid Gel each 5ml containing dried Aluminium Hydroxide gel IP 250mg, Magnesium hydroxide NF 250mg and Methyl Polysiloxane 50mg Bottle of 170 ml , Anti haemorrhoidal ointment containing Hydrocortisone acetate 5.58mg, Framycetin 10mg, Heparin 100IU, Esculoside 10mg, Ethylaminobenzoate 10mg, Butylaminobenzoate 10mg per gm tube of 10 gm , Dicyclomine HCl 20mg Inj , Hyoscine Bromide Inj 20 mg or ml ,1ml Inj , Oral Rehydration powder, sachet of 20.5 g, each containing Sodium Chloride IP 2.6 g, Anhydrous Dextrose IP 13.5 g, Potassium Chloride IP 1.5 g and Sodium Citrate IP 2.9 gm to make the mixture , Loperamide 2mg Tab , Tab Thyroxine 50 mcg , Xylometazoline HCl 0.05 percent wv nasal solution for paed use, bott of 10ml , Cetirizine Syp 5mg or 5ml bott of 60 ml , Cyproheptadine HCl 2 mg or 5 ml bott of 100 ml , Ondansetron Syp 2 mg or 5ml in bott of 30 ml , Iron drops Paediatric. Each ml contains Ferrous Fumarate containing 10 12.5 mg elemental Iron, Folic Acid 0.1 0.5 mg and Vit B12 3 10 mcg, bottle of 15 ml , Ipratropium Bromide Respirator soln 500 mcg 2 ml respule , Levo Salbutamol aerosol pack of 200 metered doses each metered dose supplies 50 mcg of Levo Salbutamol , Levo Salbutamol Sulphate, 2.5 ml, containing 1.25 mg, Respule , Dextrose Inj 25 percent, 25 ml Inj , Multi Vit Inj IV 2 10 ml with minimum constituents having Thiamine B1 30mg or ml, Pyridoxine B6 30mg or ml and B12 Cyanocobalamin 300 mcg or ml , Tab Etoricoxib 90 mg , Amoxycillin oral susp containing Amoxycillin base 125 mg per 5 ml after reconstitution bottle of 30 ml , Artemether 80 mg, Lumefantrine 480 mg Tablet , Tetanus Toxoid, purified, absorbed rubber capped, Vial of 5 ml 10 Doses , Tab Aceclofenac Sodium 100mg plus Paracetamol 500mg , Syp Chlopheniramine Maleate Maleate 1mg plus Phenylephrine 2.5 mg bott of 100ml , Oint Povidine Iodine tube of 30gm , Mouth ulcer gel tube of 10 gm Choline Salicylate , Diclofenac Spray bott of 60ml , Betadine Gargle bott of 100ml
Ministry Name
Organisation Name

Financial Information

Bid Offer Validity
120 (Days)
Arbitration Clause
No
Mediation Clause
No

Evaluation and Technical Information

Evaluation Method
Total value wise evaluation
Inspection Required
No

Tender Documents

4 Documents
GeM-Bidding-7919775.pdfMain Document
BOQ DocumentBOQ BOQ
BOQ DocumentBOQ BOQ
GEM General Terms and Conditions DocumentGEM_GENERAL_TERMS_AND_CONDITIONS

Similar Tenders

View All

Frequently Asked Questions

The qualification requirements include being a registered entity in the pharmaceutical sector with valid licenses and certifications. Participants must also demonstrate past experience in supplying similar medical products. It’s critical that bidders adhere to the regulatory standards outlined by healthcare authorities to establish credibility and reliability in fulfilling the tender obligations.

Bidders should provide various essential certificates to validate compliance with safety, quality, and efficacy standards. Documentation may include ISO certifications, healthcare product safety data sheets, and quality assurance certifications. These documents are crucial in affirming the credibility of the products proposed under this tender.

The registration process requires potential bidders to create an account on the designated tendering platform. Once registered, they must fill out the tender application, providing all necessary company information and documents as required in the submission guidelines. It’s important to follow all stipulated processes to ensure eligibility.

The accepted document formats for submission typically include PDF and Word documents. Bidders should ensure that files are not corrupted and comply with submission size limits outlined in the tender guidelines. Clarity in documentation is crucial for a smooth evaluation process.

The payment terms generally include milestones tied to delivery stages, ensuring that payment is contingent upon meeting all quality and quantity stipulations. Participants must familiarize themselves with the specific payment conditions highlighted in the tender to avoid discrepancies post-award.

Yes, the tender includes provisions that favor Micro, Small, and Medium Enterprises (MSEs) by offering advantages such as reduced financial requirements and easier compliance norms. Additionally, the tender encourages local sourcing and adherence to the ‘Make in India’ policies, enhancing local manufacturing and procurement practices.

These FAQs aim to clarify the primary aspects of tender participation and provide insights into compliance requirements, enhancing the overall comprehension for potential bidders.

Probable Bidders

Companies likely to bid

Get Tender Alerts

Get notifications for similar tenders